In light of this, GLP-1 RAs provide a high potential of being incorporated into diabetic patients' treatment plans, similar to SGLT-2 inhibitors, as they decrease MACE by 14%, macroalbuminuria by 26%, and the risk of all-cause mortality by 12% [15,49]
Once patients get to mid to high doses of 8 to 12 mg, costs rise precipitously
Trends Endocrinol Metab 2019;30:701-9.ArticlePubMed 104
The effects of GLP1(736) on cells may also be indirect, mediated through insulin and glucagon released by and cells, respectively, which can alter somatostatin secretion
When you're dealing with nausea at midnight or have questions about adjusting your dose, that around-the-clock availability matters
These drugs can help reduce appetite, increase feelings of fullness, and slow gastric emptying, making them an effective tool for weight management